Are you Dr. Weisberger?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
481 Edward H Ross Dr
Elmwood Park, NJ 07407Phone+1 201-791-2600
Summary
- Dr. James Weisberger, MD is a board certified pathologist in Elmwood Park, New Jersey. He is currently licensed to practice medicine in New Jersey, Virginia, and District of Columbia.
Education & Training
- Westchester Medical CenterResidency, Pathology-Anatomic and Clinical, 1991 - 1994
- California Pacific Medical CenterResidency, Pathology-Anatomic and Clinical, 1990 - 1991
- California Pacific Medical CenterResidency, Internal Medicine, 1983 - 1986
- Perelman School of Medicine at the University of PennsylvaniaClass of 1983
Certifications & Licensure
- VA State Medical License 2020 - 2026
- FL State Medical License 2008 - 2026
- NY State Medical License 1991 - 2026
- AR State Medical License 2009 - 2026
- NJ State Medical License 1999 - 2025
- TX State Medical License 2009 - 2025
- TN State Medical License 2008 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
- Join now to see all
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- 89 citationsCD5- mantle cell lymphoma.Zach Liu, Henry Y. Dong, Wojciech Gorczyca, Patricia Tsang, Patti Cohen
American Journal of Clinical Pathology. 2002-08-01 - 98 citationsViral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.Stephen M Kissler, Joseph R. Fauver, Christina D. Mack, Scott W. Olesen, Caroline G. Tai
Plos Biology. 2021-07-12 - 67 citationsB-Cell Lymphomas With Coexpression of CD5 and CD10Henry Y. Dong, Wojciech Gorczyca, Zach Liu, Patricia Tsang, C. Daniel Wu
American Journal of Clinical Pathology. 2003-02-01
Press Mentions
- OPKO Health’s BioReference Laboratories to Participate in the National Cancer Institute NCI-MATCH (Molecular Analysis for Therapy Choice) Phase II Clinical TrialAugust 28th, 2018
- NKF Collaborates with Laboratories, Societies to Standardize Testing for CKDFebruary 21st, 2018
- Letters, 9/17September 18th, 2017
- Join now to see all